Psychedelic Medicine
Association
That landscape is rapidly changing. There is an ever-growing number of places that are recognizing psychedelic medicines for the true therapeutic benefit they can bring.
With victories in Oregon and DC, five cities have decriminalized plant-derived psychedelics and one state has made the therapeutic use of psilocybin (magic mushrooms) legal.
Monthly newsletters with the latest findings from the world of psychedelic research.
Monthly Members-only webinars featuring panels of experts members can interact with directly.
Multiple forums where members can ask questions, exchange ideas, and discuss best practices.
Members-only journal club led by experts. Go above and beyond to understand the science.
Exclusive members-only discounts on our CME/CE accredited conferences and courses.
Our mission is to educate primary care providers, therapists, psychiatrists, and other front-line medical workers on the currently-available and soon-to-be-approved psychedelic medicines.
Because the research can’t be denied:
And those findings are just the beginning. New research findings are coming out regularly that support the use of psychedelic medicines for a number of difficult-to-treat mental and physical conditions.
Patients have suffered long enough with therapeutic options that bring little relief. It’s time we explore this new world of options so we can begin helping them truly heal.
Our community of healthcare professionals is dedicated to advancing the field of healthcare through education, networking, and collaboration. As a member of our association, you will have access to a wealth of resources designed to help you stay up-to-date on the latest industry trends and best practices.
Members can purchase access to courses at a later date.